Literature DB >> 3556740

Microtubules as target organelles for benzimidazole anthelmintic chemotherapy.

K Gull, P J Dawson, C Davis, E H Byard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3556740     DOI： 10.1042/bst0150059

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  12 in total

1.  Fasciola hepatica: localization and partial characterization of tubulin.

Authors:  A W Stitt; I Fairweather; A G Trudgett; C F Johnston
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.

Authors:  Le Zhang; Milana Bochkur Dratver; Taha Yazal; Kevin Dong; Andrea Nguyen; Garrett Yu; Amy Dao; Michael Bochkur Dratver; Sara Duhachek-Muggy; Kruttika Bhat; Claudia Alli; Frank Pajonk; Erina Vlashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-07       Impact factor: 7.038

3.  Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.

Authors:  Christopher Ma; Johnson Tran; Frank Gu; Roxanna Ochoa; Catherine Li; David Sept; Karl Werbovetz; Naomi Morrissette
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

4.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

5.  Impairment of the ubiquitin-proteasome pathway by methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate leads to a potent cytotoxic effect in tumor cells: a novel antiproliferative agent with a potential therapeutic implication.

Authors:  Nilambra Dogra; Tapas Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

6.  Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways.

Authors:  Nilambra Dogra; Ashok Kumar; Tapas Mukhopadhyay
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

7.  Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information.

Authors:  Teppei Yamaguchi; Junichi Shimizu; Yuko Oya; Yoshitsugu Horio; Toyoaki Hida
Journal:  Case Rep Oncol       Date:  2021-06-17

8.  Lipid-free antigen B subunits from echinococcus granulosus: oligomerization, ligand binding, and membrane interaction properties.

Authors:  Valeria Silva-Álvarez; Gisela R Franchini; Jorge L Pórfido; Malcolm W Kennedy; Ana M Ferreira; Betina Córsico
Journal:  PLoS Negl Trop Dis       Date:  2015-03-13

9.  Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice.

Authors:  Jintao Wang; Hui Wang; Chiao Guo; Wei Luo; Alyssa Lawler; Aswin Reddy; Julia Wang; Eddy B Sun; Daniel T Eitzman
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.

Authors:  Tara Williamson; Ren-Yuan Bai; Verena Staedtke; David Huso; Gregory J Riggins
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.